Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations
描述肠道微生物群及其衍生代谢物在多种族人群痴呆症发展中的作用
基本信息
- 批准号:10592025
- 负责人:
- 金额:$ 22.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAccelerationAddressAffectAge-associated memory impairmentAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAlzheimer&aposs disease therapyAnti-Inflammatory AgentsApplications GrantsAwardBacteriaBacteroidesBiochemistryBioinformaticsBiologyBloodBlood - brain barrier anatomyBrainCaringCause of DeathCentral Nervous SystemChronologyCollaborationsCommunicationDataDementiaDependenceDevelopmentDiagnosisDietDiseaseEpisodic memoryEscherichiaEthnic OriginEthnic PopulationEtiologyFoundationsFramingham Heart StudyFunctional disorderFundingFutureGeneticGoalsHispanic PopulationsHuman MicrobiomeIndividualInflammatoryInfrastructureLearningLinkLongitudinal StudiesMagnetic Resonance ImagingMalignant NeoplasmsMass Spectrum AnalysisMeasuresMemoryMentored Research Scientist Development AwardMentorsMetabolicMetabolismMethodsMicrovascular DysfunctionModelingNeurocognitiveNeurodegenerative DisordersNeuropsychologyNot Hispanic or LatinoNutrientObesityOutcome MeasurePathogenicityPathologyPharmaceutical PreparationsPhysiologyPlasmaPopulationPopulations at RiskPrevalencePrevotellaReportingResearchRisk FactorsRoleSex DifferencesShigellaSignal TransductionSouth TexasStructureTestingTexasTherapeuticThinkingTimebacterial communitybacterial metabolismbrain healthcareercerebral atrophycohortdrug developmentendophenotypeethnic differenceethnoracial minorityexecutive functionexperiencefecal microbiotagut dysbiosisgut microbesgut microbiomegut microbiotahigh riskinnovationinsightinterestlipidomicsmagnetic resonance imaging biomarkermathematical modelmetabolomemetabolomicsmicrobialmicrobial communitymicrobiomemicrobiotamicrobiota metabolitesmicrobiota-gut-brain axismild cognitive impairmentminority patientmodifiable riskmulti-ethnicneuroimagingneuroimaging markernew therapeutic targetnovelnovel markernovel strategiespopulation stratificationpreventprocessing speedpublic health relevanceresponserisk stratificationsexstructural biologystudy populationsystemic inflammatory responsetargeted treatmentvisual memorywhite matter
项目摘要
Abstract.
Alzheimer's disease (AD) and AD-related dementias (AD/ADRD), with a worldwide prevalence of 50
million in 2018, will surpass cancer as the leading cause of death by 2040. However, efforts to prevent, cure, or
even treat AD/ADRD have been unsuccessful. Genetic, blood, and MRI biomarkers can be used for risk
stratification, but there are limited disease-modifying options for those at high risk. Moreover, while ethnic
differences in AD/ADRD prevalence have been reported, patients of minority ethnoracial groups often receive
delayed diagnosis or inadequate treatment options. Thus, efforts are needed to identify modifiable risk factors
that could stratify the population at risk, reverse the disease course, and determine novel biomarkers for
understudied populations.
The gut microbiota, a modifiable risk factor, has been shown to interact with the central nervous system
through the bidirectional gut-microbiota-brain axis and thus, affecting brain physiology and pathology. In this
application for a K01 award, Dr. Bernard Fongang, a Bioinformatician at the Glenn Biggs Institute for Alzheimer's
and Neurodegenerative Diseases and the South Texas Alzheimer's disease Research Center will leverage data
from two cohorts to study the association between the gut microbiome and AD/ADRD endophenotypes. In Aim
1, he will examine whether the gut microbiota features (bacteria abundance and diversity) are related to various
neuroimaging and neurocognitive markers of AD/ADRD, using data from the Framingham Heart Study and the
Texas Alzheimer's Research and Care Consortium (TARCC). In Aim 2, Dr. Fongang will assess the plasma
metabolomics profiles of these markers. Finally, in Aim 3, he will use integrative omics methods and sophisticated
mathematical models to identify the microbiota-derived metabolites related to neuroimaging and
neuropsychological markers of ADRD and how they are linked with incident AD. The large proportion of
Hispanics within the TARCC study population will also allow for examining differences by ethnicity and sex. The
results of this study will serve as the foundation for an R01 grant application, to be completed by year 3 of the
award.
Along with funding for this innovative and important research, this K01 will provide Dr. Fongang with the
support necessary to achieve his goal of becoming an independently-funded leader in identifying novel biology
and novel drug targets to accelerate drug development for ADRD. Dr. Fongang has assembled a mentoring
team comprised of Dr. Sudha Seshadri, founding director of the Biggs Institute, as the primary mentor, and three
co-mentors: Dr. Joseph Petrosino, an expert in human microbiome; Dr. Patrick Sung, Chair of Biochemistry and
structural biology with extensive mentoring experience; and Dr. Xianlin Han, an expert in lipidomics and
metabolomics. In collaboration with his mentoring team, he has also developed a detailed plan of coursework
and readings to help him achieve his research- and career-based goals.
抽象。
阿尔茨海默病(AD)和AD相关痴呆(AD/ADRD),全球患病率为50
到2040年,2018年将超过癌症,成为死亡的主要原因。然而,预防、治疗或
即使治疗AD/ADRD也不成功。遗传、血液和MRI生物标志物可用于风险评估
分层,但对于那些处于高风险的人来说,疾病修饰的选择有限。此外,虽然种族
据报道,AD/ADRD患病率存在差异,少数民族患者经常接受
诊断延迟或治疗选择不足。因此,需要努力查明可改变的风险因素
这可以对高危人群进行分层,逆转疾病进程,并确定新的生物标志物,
研究不足的人群。
肠道微生物群是一种可改变的风险因素,已被证明与中枢神经系统相互作用
通过双向肠道-微生物群-脑轴,从而影响脑生理学和病理学。在这
申请K 01奖,伯纳德博士Fongang,生物信息学家在格伦比格斯研究所阿尔茨海默氏症
南德克萨斯阿尔茨海默病研究中心将利用数据
研究肠道微生物组与AD/ADRD内表型之间的关联。在Aim中
1,他将研究肠道微生物群特征(细菌丰度和多样性)是否与各种
AD/ADRD的神经影像学和神经认知标志物,使用来自心脏研究和
得克萨斯州阿尔茨海默氏症研究和护理联盟(TARCC)。在目标2中,Fongang博士将评估血浆
这些标记的代谢组学特征。最后,在目标3中,他将使用综合组学方法和复杂的
数学模型,以确定与神经成像相关的微生物衍生的代谢物,
ADRD的神经心理学标志物以及它们如何与AD事件相关联。很大比例的
TARCC研究人群中的西班牙裔也将允许检查种族和性别的差异。的
这项研究的结果将作为R 01赠款申请的基础,将在2010年的第3年完成。
奖
沿着这项创新和重要研究的资金,K 01将为Fongang博士提供
他的目标是成为一个独立资助的领导者,在确定新的生物学
和新的药物靶点,以加速ADRD的药物开发。方刚博士召集了一个
团队由比格斯研究所的创始主任Sudha Seshadri博士作为主要导师,
共同导师:Joseph Petrosino博士,人类微生物组专家;帕特里克宋博士,生物化学和
具有丰富指导经验的结构生物学;以及脂质组学专家和
代谢组学在与他的指导团队合作,他还制定了详细的课程计划
和阅读,以帮助他实现他的研究和职业为基础的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernard Fongang其他文献
Bernard Fongang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Standard Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 22.04万 - 项目类别:
Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 22.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)